Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer
Clinical trial NCT05883670 · UNKNOWN
Trial details
- NCT number
- NCT05883670
- Sponsor
- Shandong University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-09
- Primary completion
- 2024-03-31
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.